Dr. McAlpine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2775 Laurel St, 6th Floor Academic offices
Vancouver BC
San Francisco, CA 94125Phone+1 604-875-5608
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Obstetrics and Gynecology, 1997 - 2001
- Johns Hopkins University School of MedicineClass of 1996
Certifications & Licensure
- CA State Medical License 1998 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- 1 citationsSelective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas.Amy Jamieson, Melissa K McConechy, Amy Lum, Janine Senz, Tanner Dowhy
Journal of Gynecologic Oncology. 2025-01-01 - Prognostic Significance of Disseminated Tumor Cells in Bone Marrow for Endometrial Carcinoma Patients.Léa Louise Volmer, Marcel Grube, Annika Rohner, Jessica Nell McAlpine, Aline Talhouk
Journal of Clinical Medicine. 2024-07-31 - 11 citationsHarmonized molecular classification; assessment of a single-test ProMisE NGS tool.Amy Jamieson, Melissa K McConechy, Amy Lum, Samuel Leung, Emily F Thompson
Gynecologic Oncology. 2023-08-01
Authored Content
- Extending the Safety Evidence for Opportunistic Salpingectomy in Prevention of Ovarian Cancer: A Cohort Study from British Columbia, CanadaMay 2018
- Extending the Safety Evidence for Opportunistic Salpingectomy in Prevention of Ovarian CancerMay 2018
Press Mentions
- Scientists Discover High-Risk Form of Endometrial Cancer — and How to Test for It — Using AIJune 27th, 2024
- Endometrial Cancer: A High-Risk Form DiscoveredJuly 3rd, 2024
- AI Tool Identifies High-Risk Subtype of Endometrial CancerJuly 3rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: